Clinical Trial Update: Everolimus in Treating Patients With Advanced or Metastatic Colorectal Cancer That Did Not Respond to Previous Therapy [Phase 2]

View source ↗

Summary

A Phase 2 trial of everolimus in patients with advanced or metastatic colorectal cancer refractory to prior therapy was terminated, and results were posted in 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Everolimus (everolimus)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Colorectal Cancer | Phase 2 | Status: TERMINATED | Results posted: 2014-10-08